Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Husband discusses wife’s improvement after treatment at the INR in Boca Raton, Florida, in December of 2017.
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Tobinick E, Ignatowski, T., Spengler, R. On Overcoming Barriers to Application of Neuroinflammation Research. In: Abreu GEA, ed. Mechanisms of Neuroinflammation: InTechOpen; 2017.
Toni’s long-time personal assistant describes his rapid improvement after stroke treatment in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2018 INR PLLC, all rights reserved.
Family from Mumbai, India to the INR in 2015 & May 2017
Family from Mumbai, India on their second visit to the INR, in May 2017. First visit and treatment at the INR was in November 2015, four years after her stroke. The family discusses her neurological improvement after her first treatment at the INR. Her neurological improvement increased month after month and now has been sustained for 1 1/2 years and counting.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2018 INR PLLC, all rights reserved.
Patient traveled from Colorado to the INR in Boca Raton, Florida, in April 2017.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2017 INR PLLC, all rights reserved.
This website, perispinaletanercept.com, discusses the practical utility of the pioneering work of Edward Tobinick, M.D., the founder and Director of the Institute of Neurological Recovery with perispinal etanercept. Dr. Tobinick invented the remarkable, groundbreaking, perispinal etanercept treatment for brain disorders in 1999. Now, in 2025, there have been more than 5,000 patients with chronic stroke symptoms successfully treated by Dr. Tobinick, and thousands more treated for other medical indications, including brain injury (due to trauma, cardiac arrest, etc.), Alzheimer's disease, Long COVID, and additional illnesses involving neuroinflammation. Dr. Tobinick has now treated patients from every state in the U.S. and from 108 countries.
In October 2018, the Australian Government announced their designation of substantial funding to study perispinal etanercept (PSE) for treatment of stroke. On January 3, 2020 a university, double-blind, randomized, placebo-controlled, clinical trial confirmed the efficacy of perispinal etanercept for treatment of chronic neurological symptoms after stroke. As well as being the inventor of the perispinal etanercept treatment, Dr. Tobinick was instrumental in the design of the university study.
The Institute of Neurological Recovery accepts patients for treatment from all parts of the world, and has treated patients from every populated continent of the world.
Scientific articles from more than 4,600 of academic scientists around the world have cited Dr. Tobinick's scientific publications.
